期刊文献+

铜绿假单胞菌耐药性与抗菌药物使用强度相关性分析 被引量:3

Correlation between antimicrobial resistance and antimicrobial resistance of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的探讨铜绿假单胞菌耐药性与抗菌药物使用强度的相关性。方法于2015年5月至2017年12月,统计分析笔者所在医院收治的住院患者的抗菌药物应用情况,同时分析此阶段送检标本中的铜绿假单胞菌耐药性。结果住院患者的抗菌药物使用强度与铜绿假单胞菌耐药性r为-0. 33-0. 89,铜绿假单胞菌对氨曲南的使用强度、耐药性r为0. 89,两者之间差异有统计学意义(P<0. 05)。结论住院患者的抗菌药物使用强度降低,铜绿假单胞菌耐药性也随之而降低,说明临床应用抗菌药物对患者进行治疗时需慎重选择,以降低铜绿假单胞菌耐药性。 Objective To investigate the relationship between the resistance of Pseudomonas aeruginosa and the intensity of antimicrobial use. Methods In May 2015 to December 2017,the application of antibiotics in the hospitalized patients in my hospital was analyzed,and the drug resistance of Pseudomonas aeruginosa in this stage was analyzed. Results The drug use intensity of the hospitalized patients and the drug resistance of Pseudomonas aeruginosa r were-0. 33-0. 89,and the use intensity and resistance R of Pseudomonas aeruginosa to aztreonam were 0. 89,and the correlation between them was statistically significant( P<0. 05). Conclusion The drug use intensity of hospitalized patients is lower,and the resistance of Pseudomonas aeruginosa is also decreased. It shows that the clinical application of antibiotics should be carefully selected to reduce the drug resistance of Pseudomonas aeruginosa.
作者 席云生 魏华 XI Yunsheng;WEI Hua(Peixian People’s Hospital,Jiangsu Xuzhou 221600,China)
出处 《现代医学与健康研究电子杂志》 2018年第16期14-14,16,共2页 Modern Medicine and Health Research
关键词 铜绿假单胞菌 耐药性 抗菌药物 使用强度 相关性 pseudomonas aeruginosa drug resistance antimicrobial agents intensity of use correlation
  • 相关文献

参考文献5

二级参考文献44

  • 1闫敏.2009~2011年某院临床常见病原菌分布及耐药分析[J].国际检验医学杂志,2012,33(S1):58-60. 被引量:4
  • 2张祎博,倪语星,孙景勇,朱德妹,胡付品,汪复,蒋晓飞,俞云松,杨青,孙自镛,简翠,徐英春,孙宏莉,胡云建,艾效曼,单斌,杜艳,苏丹虹,卓超,徐元宏,沈继录,王传清,王爱敏,贾蓓,黄文祥,魏莲花,吴玲,张朝霞,季萍,张泓,李万华.2009年中国CHINET铜绿假单胞菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):436-440. 被引量:74
  • 3周霞,王鹏.灰色关联分析在医学中的应用[J].辽宁中医杂志,2006,33(8):938-939. 被引量:15
  • 4颜英俊,糜祖煌,刘华,杨洋,张凯,杨明清,黄文方.耐亚胺培南铜绿假单胞菌耐药特征及其耐药机制的研究[J].中华医院感染学杂志,2007,17(6):627-630. 被引量:43
  • 5卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[z].卫办医政发[2009]38号.
  • 6Weyers CM,Clemens S,Leeper KV.Pseudomonas aerugino-sa ventilator-associated pneumonia:A comparison of clinicaloutcomes among resistant versus susceptible organism at Em-ory-Crawford long hospital[J].Chest,2005,128:143s.
  • 7Niederman MS.Hospital-acquired pneumonia,health care-as-sociated pneumonia,ventilator-associated pneumonia,andventilator-associated tracheobronchitis:definitions and chal-lenges in trial design[J].Clin Infect Dis,2010,51(Suppl1):S12-S17.
  • 8Falagas ME,Koletsi PK,Bliziotis IA.The diversity of defini-tions of multidrug-resistant(MDR)and pandrug-resistant(PDR)Acinetobacter baumannii and Pseudomonas aeruginosa[J].J Med Microbiol,2006,55(Pt12):1619-1629.
  • 9Falagas ME,Bliziotis IA,Kasiakou SK,et al.Outcome of in-fections due to pandrug-resistant(PDR)Gram-negative bacte-ria[J].BMC Infect Dis,2005,5:24.
  • 10Onguru P,Erbay A,Bodur H,et al.Imipenem-resistant Pseudo-monas aeruginosa:risk factors for nosocomial infections[J].J Ko-rean Med Sci,2008,23(6):982-987.

共引文献90

同被引文献33

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部